Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Capsular involvement in patients undergoing partial nephrectomy for localized renal cell carcinoma: an adverse pathological finding
BJU International, 08/14/09
Rouach Y et al. – In a trial to evaluate the prognostic impact of capsular involvement (CaI) in pts treated exclusively with partial nephrectomy (PN) for localized renal cell carcinoma (RCC), it was found that in a contemporary series of pts exclusively treated with PN for localized RCC, CaI was not predictive of disease recurrence and disease-specific mortality. These results do not support the use of any change in postoperative management in pts with CaI after PN.
Methods- Medical records were reviewed of pts treated with PN for a sporadic and localized RCC (pT1-pT2N0M0).
- Univariate and multivariate analysis using a Cox proportional-hazards regression analysis were conducted to identify significant predictors of oncological outcome for several clinical and pathological factors, ie, imperative indication, histological type, Fuhrman grade, tumour size, T stage, CaI, and surgical margins.
- Disease-free and -specific survival rates of pts with CaI and no evidence of CaI were compared using the log-rank test.
- 305 pts had a PN for localized RCC, of whom 22 (7.2%) had CaI in the PN specimen.
- Median (range) follow-up was 6 (1.5–23) yrs.
- Multivariate statistical analysis showed that imperative indication for PN and high-grade RCC were independently associated with worse disease-free and -specific survival, whereas CaI had no prognostic value.
- Disease-free and -specific survival in pts with and without CaI were not significantly different at 5 and 10 yrs.
Related Articles
Prognostic Value of Capsular Invasion for Localized Clear-Cell Renal Cell Carcinoma
European Urology, 11/10/09
Relevance Score: 90%
Multidisciplinary treatment including sorafenib stabilized the bone metastases of renal cell carcinoma in an immunosuppressed renal transplant recipient
International Journal of Clinical Oncology, 10/30/09
Relevance Score: 90%
Conditional Survival Predictions After Nephrectomy for Renal Cell Carcinoma
The Journal of Urology, 11/18/09
Relevance Score: 89%
Laparoscopic Radical Nephrectomy for Renal Cell Carcinoma: Oncological Outcomes at 10 Years or More
The Journal of Urology, 10/15/09
Relevance Score: 89%
Positive Surgical Margins With Renal Cell Carcinoma Have a Limited Influence on Long-term Oncological Outcomes of Nephron Sparing Surgery
Urology, 11/12/09
Relevance Score: 88%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Update on novel agents in renal cell carcinoma
Expert Review of Anticancer Therapy, 12/08/09
Imprint cytologic features of chromophobe renal cell carcinoma morphologically resembling renal oncocytoma: Is this an oncocytic variant of chromophobe renal cell carcinoma
Diagnostic Cytopathology, 12/08/09
Carcinoid tumor of the kidney: An unusual renal tumor
Indian Journal of Urology, 12/08/09
Article Search
Sponsor


See Latest Articles


